DRKS00027314招募中不适用
ongitudinal study of immune response and epigenetics in acute LongCovid syndrome secondary to COVID-19 disease.
Klinik I für Innere MedizinUniversitätsklinikum Köln (AöR)0 个研究点目标入组 100 人开始时间: 2023年1月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Good physical condition (Karnofsky index =80%).
- •Previous laboratory diagnostic evidence of SARS-CoV-2 infection.
- •Current existing LongCovid syndrome.
排除标准
- •Hemoglobin <10 g/dL
- •Symptomatic heart disease (e.g., heart failure NYHA =II, coronary artery disease)
- •previous myocardial infarction
- •COPD Stage GOLD III-IV
- •Body weight less than 45kg
- •<8 weeks (men) or <12 weeks (women) since last blood collection of =500 ml
研究者
相似试验
已完成
不适用
Characterisation of COVID-19 long-term immunityCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN11946807niversity of Bristol372
已完成
不适用
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)Chronic Beryllium DiseaseNCT02604693National Jewish Health148
尚未招募
不适用
Study to the humoral and cellular immuneresponse after influenzavaccination in patients with metastasized RCC or GIST treated with a tyrosine kinase inhibitor(sunitinib or sorafenib)kidney cancer10038363GISTNL-OMON32710niversitair Medisch Centrum Sint Radboud75
招募中
4 期
Immune response after two doses of COVID-19 vaccinatioCoronavirus Disease 2019D000086382JPRN-jRCT1051210161Kayeka Hiroshi600
进行中（未招募）
不适用
A study of humoral and cellular-mediated immune response in Monoclonal gammopathy of Undetermined Significance after vaccination with trivalent inactivated influenza vaccine (influvac) - mgus-vacc responsMonoclonal Gammopathy of Undetermined significanceEUCTR2010-022693-14-NLuniversity medical centre groningen